HealthEquity, Inc.

HQY Healthcare Health Information Services

HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

92.03 0.48 −0.52%
Market cap
$7.7B
P/E
33.0×
Fwd P/E
30.2×
Dividend yield
—
F-score
9/9
Altman Z
4.39
Beneish M
−2.77
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jul '26 Apr '26 Jan '26 Oct '25 Older periods
Net Income
65.64 69.42 49.74 51.69

+8 more quarters

Depreciation & Amortization
42.26 38.30 38.94 39.05
Non Cash Items (Other)
31.43 29.51 16.11 32.57
Accounts Receivable Change
(0.19) 1.69 (12.45) (0.08)
Accounts Payable Change
(12.72) (0.87) 12.98 (7.48)
Change in payables and accrued liability
10.15 (31.24) 15.83 10.39
Change in other assets and liabilities
(0.41) (9.28) (3.23) 12.44
Operating Cash Flow
136.16 97.53 117.92 138.58
Capital expenditures
(15.77) (16.29) (10.07) (11.09)
Change in intangibles (net)
— — 0.00 (0.29)
Other investing activities
(10.15) 2.39 1.64 —
Investing cash flow
(25.91) (13.90) (8.44) (11.38)
Repayment/Issuance of Debt (Net)
(11.87) (15.00) (25.00) (25.00)
Equity Repurchase (Common, Net)
(107.50) (122.90) (75.06) (97.42)
Other financial activities
(0.24) 0.72 0.25 0.03
Financing cash flow
(119.61) (137.18) (99.81) (122.40)
Change in Cash
(9.37) (53.56) 9.67 4.80
Beginning Cash
0.00 318.93 0.00 0.00
Ending Cash
(9.37) 265.37 9.67 4.80
Stock Based Compensation
22.21 19.41 19.12 20.54
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Net Cash/Marketcap
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(3.17) (39.70) 13.12 15.27
Issuance/Purchase of Shares
(107.50) (122.90) (75.06) (97.42)

Fold the line items

In millions of $ except per-share values · columns are period end dates